Current Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 23 Issue: 23
Author(s): Paola Perego
Affiliation:
Export Options
About this article
Cite this article as:
Perego Paola, Meet Our Editorial Board Member, Current Medicinal Chemistry 2016; 23 (23) . https://dx.doi.org/10.2174/092986732323160823184550
DOI https://dx.doi.org/10.2174/092986732323160823184550 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
28
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Development of Small-Molecule Inhibitors of Raf
Recent Patents on Anti-Infective Drug Discovery Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
Anti-Cancer Agents in Medicinal Chemistry Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Current Cancer Drug Targets Clinical Trials Investigating Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
Reviews on Recent Clinical Trials Damaged Proteins Bearing L-Isoaspartyl Residues and Aging: A Dynamic Equilibrium Between Generation of Isomerized Forms and Repair by PIMT
Current Aging Science Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Current Cancer Drug Targets Gene therapy for Multiple Myeloma
Current Gene Therapy Recent Advances in the Development of Selective CB2 Agonists as Promising Anti-Inflammatory Agents
Current Medicinal Chemistry The Function and Regulation of BMP6 in Various Kinds of Stem Cells
Current Pharmaceutical Design microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Mucin-based Targeted Pancreatic Cancer Therapy
Current Pharmaceutical Design Flavonoids and Linderone from Lindera oxyphylla and their Bioactivities
Combinatorial Chemistry & High Throughput Screening Anti-Cancer Therapies that Utilize Cell Penetrating Peptides
Recent Patents on Anti-Cancer Drug Discovery Spongistatins as Tubulin Targeting Agents
Current Pharmaceutical Design Retraction Note: Low Doses of CPS49 and Flavopiridol Combination as Potential Treatment for Advanced Prostate Cancer
Current Pharmaceutical Biotechnology Vitamin D and Asthma: Scientific Promise and Clinical Reality
Current Respiratory Medicine Reviews Synthesis, Characterization and Evaluation of 1,3-Bisindolyl-2-Propen-1- One Derivatives as Potent Anti-Breast Cancer Agents
Current Bioactive Compounds Meditation: A Review of its Use in Western Medicine and, in Particular, its Role in the Management of Sexual Dysfunction
Current Psychiatry Reviews Immunotherapy in Liver Diseases: A Balance Between Immunity and Tolerance
Current Drug Metabolism Prediction and Monitoring of Therapeutic Response by Molecular Imaging
Current Medical Imaging